glp 1 colitis SAFETY AND CLINICAL EFFECTIVENESS OF GLP1 AGONISTS IN INFLAMMATORY BOWEL DISEASE PATIENTS Frontiers | GLP-1 and GLP-2

Hallaj S, Halfpenny W, Chuter BG, Weinreb RN, Baxter SL, Cui QN

With indications for other diseases including liver disease and Alzheimers disease currently being explored, the utilization of this drug class will only expand in the coming years

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 183,71 per year only 15,31 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References Zelniker, T

Fam Pract 2008;25:390-6